Literature DB >> 5000919

Inhibition of rat and mouse brain monamine oxidases by (+)-amphetamine.

A L Green.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5000919      PMCID: PMC1176616          DOI: 10.1042/bj1210037p

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


× No keyword cloud information.
  3 in total

1.  ENHANCEMENT BY RESERPINE AND ALPHA-METHYL DOPA OF THE EFFECTS OF D-AMPHETAMINE UPON THE LOCOMOTOR ACTIVITY OF MICE.

Authors:  C B SMITH
Journal:  J Pharmacol Exp Ther       Date:  1963-12       Impact factor: 4.030

2.  Correlation of brain levels of drugs with behavioral effects.

Authors:  R P Maickel; R H Cox; F P Miller; D S Segal; R W Russell
Journal:  J Pharmacol Exp Ther       Date:  1969-02       Impact factor: 4.030

3.  Tissue levels of chloroamphetamines in rats and mice.

Authors:  R W Fuller; C W Hines
Journal:  J Pharm Sci       Date:  1967-02       Impact factor: 3.534

  3 in total
  4 in total

1.  In vivo comparison of harmine efficacy against psychostimulants: preferential inhibition of the cocaine response through a glutamatergic mechanism.

Authors:  Suzan Owaisat; Robert B Raffa; Scott M Rawls
Journal:  Neurosci Lett       Date:  2012-08-03       Impact factor: 3.046

2.  Interactions of methylenedioxymethamphetamine with monoamine transmitter release mechanisms in rat brain slices.

Authors:  J L Fitzgerald; J J Reid
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-03       Impact factor: 3.000

3.  A neuronal basis for the alerting action of (+)-amphetamine.

Authors:  R J Boakes; P B Bradley; J M Candy
Journal:  Br J Pharmacol       Date:  1972-07       Impact factor: 8.739

4.  Essential role of NMDA receptor channel ε4 subunit (GluN2D) in the effects of phencyclidine, but not methamphetamine.

Authors:  Yoko Hagino; Shinya Kasai; Wenhua Han; Hideko Yamamoto; Toshitaka Nabeshima; Masayoshi Mishina; Kazutaka Ikeda
Journal:  PLoS One       Date:  2010-10-28       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.